Ask AI
H.R. 6996

Accelerating Access for Patients Act of 2022

Accelerating Access for Patients Act of 2022

This bill modifies requirements relating to accelerated approval of drugs for serious or life-threatening diseases or conditions, including by requiring guidance from the Food and Drug Administration and coordinated plans with product sponsors on appropriate postapproval studies.

Referred to the Subcommittee on Health.

Rep. McMorris Rodgers, Cathy [R-WA-5](R-WA)Sponsor
1committees4actions
  1. Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  2. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  3. IntroReferralIntro-H

    Introduced in House

  4. IntroReferral1000

    Introduced in House

Accelerating Access for Patients Act of 2022 — Informed